Arrhythmias & EP
Conference Coverage
VIDEO: Rivaroxaban gives safer protection to atrial fib patients post PCI
NEW ORLEANS – The puzzle of how to safely prevent thrombotic events in patients with atrial fibrillation who receive a coronary stent now has a...
Conference Coverage
Scoring formula consolidates stroke, bleeding risk in atrial fib patients
ROME
Conference Coverage
‘Excellent’ real-world experience with LAA closure device
A device that closes the left atrial appendage to prevent stroke in patients with nonvalvular atrial fibrillation showed a 95.6% procedural...
Conference Coverage
Interrupting oral anticoagulation in AF carries high thromboembolic cost
ROME – Interrupting oral anticoagulation for more than 3 days in patients with atrial fibrillation places them at sharply increased risk of...
Conference Coverage
Adaptive servo ventilation cuts atrial fib burden
Adaptive servo ventilation appeared to substantially reduce atrial fibrillation burden in patients with heart failure and sleep apnea in a...
Conference Coverage
Joint European atrial fibrillation guidelines break new ground
ROME – The novel oral anticoagulants are now strongly recommended over warfarin for stroke prevention.
Conference Coverage
Beta-blockers curb death risk in patients with primary prevention ICD
ROME – Beta-blocker therapy significantly reduces the risks of cardiac death and all-cause mortality, but not sudden death, in heart failure...
Article
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
The Food and Drug Administration reaffirmed its confidence in the data supporting the claim that rivaroxaban (Xarelto) is a safe and effective...
From the Journals
Rivaroxaban linked to more bleeding compared with dabigatran in elderly patients with nonvalvular AF
Rivaroxaban is associated with significantly more intra- and extracranial bleeding than is dabigatran in older patients who have nonvalvular...